Regeneron Pharmaceuticals, Inc. (REGN) Chairman of the Board P Roy Vagelos sells 85,634 Shares

Nov 30, 2012

Chairman of the Board of Regeneron Pharmaceuticals, Inc. (REGN, Financial) P Roy Vagelos sells 85,634 shares of REGN on 11/29/2012 at an average price of $179.1 a share.

Regeneron Pharmaceuticals, Inc. has a market cap of $17 billion; its shares were traded at around $180.81 with a P/E ratio of 82.3 and P/S ratio of 38.1.

CFO Recent Trades:

SVP Finance and Admin CFO Trea Murray A Goldberg sold 9,693 shares of REGN stock on 11/14/2012 at the average price of 147.59. Murray A Goldberg owns at least 89,537 shares after this. The price of the stock has increased by 22.51% since.
SVP Finance and Admin CFO Trea Murray A Goldberg sold 5,296 shares of REGN stock on 08/31/2012 at the average price of 145.89. Murray A Goldberg owns at least 96,074 shares after this. The price of the stock has increased by 23.94% since.

Directors and Officers Recent Trades:

Director George L Sing sold 5,000 shares of REGN stock on 11/29/2012 at the average price of 185. George L Sing owns at least 130,772 shares after this. The price of the stock has decreased by 2.26% since.
Chairman of the Board P Roy Vagelos sold 85,634 shares of REGN stock on 11/29/2012 at the average price of 179.1. P Roy Vagelos owns at least 350,638 shares after this. The price of the stock has increased by 0.95% since.
Chairman of the Board P Roy Vagelos sold 64,753 shares of REGN stock on 11/27/2012 at the average price of 175.22. P Roy Vagelos owns at least 436,272 shares after this. The price of the stock has increased by 3.19% since.
Director Charles A Baker sold 15,000 shares of REGN stock on 11/26/2012 at the average price of 173.87. Charles A Baker owns at least 9,590 shares after this. The price of the stock has increased by 3.99% since.
SVP Commercial Robert J Terifay sold 9,745 shares of REGN stock on 11/23/2012 at the average price of 174.45. Robert J Terifay owns at least 10,903 shares after this. The price of the stock has increased by 3.65% since.

For the complete insider trading history of REGN, click here.

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Mobile App 中文

Education

Financial Glossary Tutorials FAQ Schedule Free Session Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us ETF Advertise Site Map Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. It has an affiliated registered investment adviser, which serves as the subadviser to an exchange traded fund. This investment adviser does not provide advice to individual investors. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Data is updated daily.